Association Between Lifestyle and Hypertriglyceridemic Waist Phenotype in the PREDIMED-Plus Study.


Journal

Obesity (Silver Spring, Md.)
ISSN: 1930-739X
Titre abrégé: Obesity (Silver Spring)
Pays: United States
ID NLM: 101264860

Informations de publication

Date de publication:
03 2020
Historique:
received: 12 07 2019
accepted: 31 10 2019
entrez: 25 2 2020
pubmed: 25 2 2020
medline: 29 8 2020
Statut: ppublish

Résumé

The hypertriglyceridemic waist (HTGW) phenotype is characterized by abdominal obesity and high levels of triglycerides. In a cross-sectional assessment of PREDIMED-Plus trial participants at baseline, HTGW phenotype prevalence was evaluated, associated risk factors were analyzed, and the lifestyle of individuals with metabolic syndrome and HTGW was examined. A total of 6,874 individuals aged 55 to 75 with BMI ≥ 27 and < 40 kg/m A total of 38.2% of the sample met HTGW HTGW is a highly prevalent phenotype in this population associated with younger age, higher BMI, tobacco use, and decreased MedDiet adherence. HTGW

Identifiants

pubmed: 32090511
doi: 10.1002/oby.22728
doi:

Substances chimiques

Triglycerides 0

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

537-543

Subventions

Organisme : European Research Council
Pays : International

Informations de copyright

© 2020 The Obesity Society.

Références

Gomez-Huelgas R, Bernal-López MR, Villalobos A, et al. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP Study (multidisciplinary intervention in primary care). Int J Obes (Lond) 2011;35:292-299.
Guattini V, Piovesan C, Wittke E, Marcadenti A. Hypertriglyceridemic waist (EWET), glycidic and lipid profile in patients with newly diagnosed heart attack. Nutr Hosp 2015;32:1004-1008.
Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.
Braz MAD, Vieira JN, Gomes FO, et al. Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points. Diabetes Metab Syndr Obes 2017;10:385-391.
Arsenault BJ, Lemieux I, Després JP, et al. The hypertriglyceridemic waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk Prospective Population Study. CMAJ 2010;182:1427-1432.
Haack RL, Horta BL, Gigante DP, Barros FC, Oliveira I, Silveira VM. The hypertriglyceridemic waist phenotype in young adults from the Southern Region of Brazil. Cad Saude Publica 2013;29:999-1007.
Bach-Faig A, Berry EM, Lairon D, et al.; Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr 2011;14:2274-2284.
Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean diet and cardiovascular health. Circ Res 2019;124:779-798.
Maki KC, Beiseigel JM, Jonnalagadda SS, et al. Whole-grain ready to eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc 2010;110:205-214.
Estruch R, Ros E, Salas-Salvadó J, et al.; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet [retracted and republished in N Engl J Med 2018;378:e34. doi:10.1056/NEJMoa1800389]. N Engl J Med 2013;368:1279-1290.
Guasch-Ferré M, Salas-Salvadó J, Ros E, et al.; PREDIMED Investigators. The PREDIMED trial, Mediterranean diet and health outcomes: how strong is the evidence? Nutr Metab Cardiovasc Dis 2017;27:624-632.
Martínez-González MA, Salas-Salvadó J, Estruch R, et al. Benefits of the Mediterranean diet: insights from the PREDIMED study. Prog Cardiovasc Dis 2015;58:50-60.
Cárdenas Fuentes G, Bawaked RA, Martínez González MÁ, et al. Association of physical activity with body mass index, waist circumference and incidence of obesity in older adults. Eur J Public Health 2018;28:944-950.
Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
Martínez-González MA, Buil-Cosiales P, Corella D, et al.; PREDIMED-Plus Investigators. Cohort profile: design and methods of the PREDIMED-Plus randomized trial. Int J Epidemiol 2019;48:387-388o. doi:10.1093/ije/dyy225
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report on a WHO Consultation (WHO Technical Report Series 894). Geneva, Switzerland: World Health Organization; 2000.
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 2004;109:433-438.
Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062.
Fernandez-Ballart JD, Pinol JL, Zazpe I, et al. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 2009;103:1808-1816.
De la Fuente-Arrillaga C, Vazquez Z, Bes-Rastrollo M, Sampson L, Martınez-Gonzalez MA. Reproducibility of a food frequency questionnaire (FFQ) validated in Spain. Public Health Nutr 2010;13:1364-1372.
Rosique-Esteban N, Díaz-López A, Martínez-González MA, et al. PREDIMED-PLUS investigators. Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: a cross-sectional analysis. PLoS One 2017;12:e0172253. doi:10.1371/journal.pone.0172253
Molina L, Sarmiento M, Peñafiel J, et al. Validation of the Regicor Short Physical Activity Questionnaire for the adult population. PLoS One 2017;12:e0168148. doi:10.1371/journal.pone.0168148
Tojal L, Alonso-Gómez A, Alberich S, et al. Association between maximal oxygen consumption and physical activity and sedentary lifestyle in metabolic syndrome. Usefulness of questionnaires [published online November 24, 2018]. Rev Esp Cardiol (Engl Ed) 2018. doi:10.1016/j.rec.2018.08.027
Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chronic Dis 2006;3:A118. http://www.cdc.gov/pcd/issues/2006/oct/06_0001.htm.
Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies. Lancet Diabetes Endocrinol 2018;6:538-546.
Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab 2013;27:501-507.
Freitas RS, Fonseca MJMD, Schmidt MI, Molina MDCB, Almeida MDCC. Hypertriglyceridemic waist phenotype: associated factors and comparison with other cardiovascular and metabolic risk indicators in the ELSA-Brasil study. Cad Saude Publica 2018;34:e00067617. doi:10.1590/0102-311X00067617
Andrade JR, Velasquez-Melendez G, Barreto SM, Pereira TSS, Mill JG, Molina MDCB. Hypertriglyceridemic waist phenotype and nutritional factors: a study with participants of ELSA-Brasil. Rev Bras Epidemiol 2017;20:382-393.
García Álvarez A, Serra-Majem L, Castell C, Ribas-Barba L, Méndez MA. Trends in the association between smoking history and general/central obesity in Catalonia, Spain (1992-2003). Nutr Hosp 2017;34:102-110.
Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res 2017;122:1-7.
Jordan J, Yumuk V, Schlaich M, et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens 2012;30:1047-1055.
Fagundes LC, Fernandes MH, Brito TA, Coqueiro RDS, Carneiro JAO. Prevalence and factors associated with hypertriglyceridemic waist in the elderly: a population-based study. Cien Saude Colet 2018;23:607-616.
Martínez-González MA, Salas-Salvadó J, Estruch R, Corella D, Fitó M, Ros E. Benefits of the Mediterranean Diet: insights from the PREDIMED study. Prog Cardiovasc Dis 2015;58:50-60.
Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr 2018;72:30-43.
Catapano AL, Graham I, De Backer G, et al.; ESC Scientific Document Group. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 2016;37:2999-3058.
Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2019;3:CD009825. doi:10.1002/14651858.CD009825.pub3
Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, et al.; PREDIMED-Plus investigators. Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial. Diabetes Care 2019;42:777-788.
Sofi F, Dinu M, Pagliai G, et al. Low-calorie vegetarian versus Mediterranean diets for reducing body weight and improving cardiovascular risk profile: CARDIVEG study. Circulation 2018;137:1103-1113.
Czernichow S, Bruckert E, Bertrais S, Galan P, Hercberg S, Oppert JM. Hypertriglyceridemic waist and 7.5-year prospective risk of cardiovascular disease in asymptomatic middle-aged men. Int J Obes (Lond) 2007;31:791-796.
Irving BA, Davis CK, Brock DW, et al. The metabolic syndrome, hypertriglyceridemic waist, and cardiometabolic risk factor profile in obese women. Obe Metab 2007;3:50-57.
Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van GL. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One 2013;8:e56415. doi:10.1371/journal.pone.0056415
Dahl-Petersen IK, Brage S, Bjerregaard P, Tolstrup JS, Jørgensen ME. Physical activity and abdominal fat distribution in greenland. Med Sci Sports Exerc 2017;49:2064-2070.
Churilla JR, Fitzhugh EC. Total physical activity volume, physical activity intensity, and metabolic syndrome: 1999-2004 National Health and Nutrition Examination Survey. Metab Syndr Relat Disord 2012;10:70-76.
Whitaker KM, Pereira MA, Jacobs DR Jr, Sidney S, Odegaard AO. Sedentary behavior, physical activity, and abdominal adipose tissue deposition. Med Sci Sports Exerc 2017;49:450-458.

Auteurs

José Carlos Fernández-García (JC)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Instituto de Investigación Biomédica de Malaga (IBIMA), Malaga, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Araceli Muñoz-Garach (A)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Instituto de Investigación Biomédica de Malaga (IBIMA), Malaga, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

Miguel Ángel Martínez-González (MÁ)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Jordi Salas-Salvado (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Unitat de Nutrició, Reus, Spain.
Nutrition Unit, University Hospital of Sant Joan de Reus, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Dolores Corella (D)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Álvaro Hernáez (Á)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.
Blanquerna, School of Health Sciences Organization, Universitat Ramon Llull, Barcelona, Spain.

Dora Romaguera (D)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Jesús Vioque (J)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Miguel Hernandez University, ISABIAL-FISABIO, Alicante, Spain.

Ángel M Alonso-Gómez (ÁM)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Cardiology, Organización Sanitaria Integrada (OSI) ARABA, University Hospital Araba, Vitoria-Gasteiz, Spain.
University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain.

Julia Wärnberg (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga-Instituto de Investigación Biomédica de Malaga (IBIMA), Málaga, Spain.

J Alfredo Martínez (JA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.
Cardiometabolic Nutrition Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Luís Serra-Majem (L)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Nutrition Research Group, Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

Ramón Estruch (R)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

José Lapetra (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.

Xavier Pintó (X)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
University of Barcelona, Barcelona, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Josep A Tur (JA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.

Antonio Garcia-Rios (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Cordoba, Spain.

Laura García Molina (L)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.

José Juan Gaforio (JJ)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Division of Preventive Medicine, Faculty of Medicine, University of Jaén, Jaén, Spain.

Pilar Matía-Martín (P)

Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.

Lidia Daimiel (L)

Nutritional Genomics and Epigenomics Group, IMDEA Food, CEI UAM + CSIC, Madrid, Spain.

Vicente Martín Sánchez (V)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Institute of Biomedicine (IBIOMED), University of León, León, Spain.

Josep Vidal (J)

CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Endocrinology, Institut d'Investigacions Biomédiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain.

Lucia Prieto (L)

Department of Endocrinology, Fundación Jiménez-Díaz, Madrid, Spain.

Emilio Ros (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Lipid Clinic, Department of Endocrinology and Nutrition, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.

Nuria Goñi (N)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.

Nancy Babio (N)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Unitat de Nutrició, Reus, Spain.
Nutrition Unit, University Hospital of Sant Joan de Reus, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Carolina Ortega-Azorin (C)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Olga Castañer (O)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d`Investigació Médica (IMIM), Barcelona, Spain.

Jadwiga Konieczna (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Leyre Notario Barandiaran (L)

CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Miguel Hernandez University, ISABIAL-FISABIO, Alicante, Spain.

Jessica Vaquero-Luna (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Cardiology, Organización Sanitaria Integrada (OSI) ARABA, University Hospital Araba, Vitoria-Gasteiz, Spain.

Juan Carlos Benavente-Marín (JC)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Nursing, School of Health Sciences, University of Málaga-Instituto de Investigación Biomédica de Malaga (IBIMA), Málaga, Spain.

M Angeles Zulet (MA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.

Almudena Sanchez-Villegas (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Nutrition Research Group, Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.

Emilio Sacanella (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Ricardo Gómez Huelgas (R)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Regional University Hospital of Malaga, Instituto de Investigación Biomédica de Malaga (IBIMA), Malaga, Spain.

Leticia Miró-Moriano (L)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain.

Mariano Gimenez-Gracia (M)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

Alicia Julibert (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.
Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain.

Cristina Razquin (C)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Josep Basora (J)

Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Unitat de Nutrició, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Olga Portolés (O)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Albert Goday (A)

University of Barcelona, Barcelona, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d`Investigació Médica (IMIM), Barcelona, Spain.

Aina M Galmés-Panadés (AM)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain.

Carmen M López-García (CM)

Centro Salud Raval de Elche, Alicante, Spain.

Anai Moreno-Rodriguez (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Cardiology, Organización Sanitaria Integrada (OSI) ARABA, University Hospital Araba, Vitoria-Gasteiz, Spain.

Estefanía Toledo (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Preventive Medicine and Public Health, University of Navarra, IDISNA, Pamplona, Spain.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Andrés Díaz-López (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Departament de Bioquímica i Biotecnologia, Universitat Rovira i Virgili, Unitat de Nutrició, Reus, Spain.
Nutrition Unit, University Hospital of Sant Joan de Reus, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Montserrat Fitó (M)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Unit of Cardiovascular Risk and Nutrition, Institut Hospital del Mar de Investigaciones Médicas Municipal d`Investigació Médica (IMIM), Barcelona, Spain.

Francisco J Tinahones (FJ)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Instituto de Investigación Biomédica de Malaga (IBIMA), Malaga, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.

M Rosa Bernal-López (MR)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
Department of Internal Medicine, Regional University Hospital of Malaga, Instituto de Investigación Biomédica de Malaga (IBIMA), Malaga, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH